JP2003506416A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003506416A5 JP2003506416A5 JP2001514981A JP2001514981A JP2003506416A5 JP 2003506416 A5 JP2003506416 A5 JP 2003506416A5 JP 2001514981 A JP2001514981 A JP 2001514981A JP 2001514981 A JP2001514981 A JP 2001514981A JP 2003506416 A5 JP2003506416 A5 JP 2003506416A5
- Authority
- JP
- Japan
- Prior art keywords
- moxifloxacin
- moxifloxacin hydrochloride
- aqueous solution
- aqueous
- converted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960005112 moxifloxacin hydrochloride Drugs 0.000 description 7
- IDIIJJHBXUESQI-DFIJPDEKSA-N moxifloxacin hydrochloride Chemical compound Cl.COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 IDIIJJHBXUESQI-DFIJPDEKSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 4
- 229960003702 moxifloxacin Drugs 0.000 description 3
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000013011 aqueous formulation Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19937116.4 | 1999-08-06 | ||
| DE19937116A DE19937116A1 (de) | 1999-08-06 | 1999-08-06 | Moxifloxacin Kochsalzformulierung |
| PCT/EP2000/007098 WO2001010465A1 (de) | 1999-08-06 | 2000-07-25 | Moxifloxacin kochsalzformulierung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003506416A JP2003506416A (ja) | 2003-02-18 |
| JP2003506416A5 true JP2003506416A5 (enExample) | 2007-09-06 |
| JP5522877B2 JP5522877B2 (ja) | 2014-06-18 |
Family
ID=7917417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001514981A Expired - Lifetime JP5522877B2 (ja) | 1999-08-06 | 2000-07-25 | モキシフロキサシン／塩化ナトリウム製剤 |
Country Status (40)
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19937116A1 (de) | 1999-08-06 | 2001-02-08 | Bayer Ag | Moxifloxacin Kochsalzformulierung |
| DE10218328A1 (de) * | 2002-03-05 | 2003-09-25 | Humboldt Uni Zu Berlin Medizin | Mittel zur präventiven Therapie nach akutem Schlaganfall |
| US20040197408A1 (en) * | 2002-12-30 | 2004-10-07 | Angiotech International Ag | Amino acids in micelle preparation |
| WO2006015545A1 (fr) * | 2004-08-11 | 2006-02-16 | Shenzhen Tys R & D Co., Ltd. | Capsule de gelatine de moxifloxacin et procede pour sa preparation |
| JO3270B1 (ar) * | 2005-06-28 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات كوينولين بصفة عوامل مضادة للبكتيريا |
| JO2752B1 (en) * | 2005-06-28 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| DE102006031175A1 (de) * | 2006-07-06 | 2008-01-10 | Bayer Healthcare Ag | Wässrige Arzneimittelformulierung von 4-[((4-Carboxybutyl)-(2[(4-phenethyl-benzyl)oxy]-phenethyl)amino)methyl]benzoesäur |
| US7537532B2 (en) * | 2007-05-16 | 2009-05-26 | Young Carl D | Handle for implement and method |
| CN101787022B (zh) * | 2009-10-09 | 2012-08-22 | 浙江医药股份有限公司新昌制药厂 | 一种喹啉羧酸盐酸盐一水合物晶型及其制备方法 |
| WO2011086577A2 (en) * | 2010-01-12 | 2011-07-21 | Msn Laboratories Limited | Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts |
| CN101836950A (zh) * | 2010-03-12 | 2010-09-22 | 陕西合成药业有限公司 | 一种盐酸莫西沙星葡萄糖注射液及其制备方法和用途 |
| CN103919779B (zh) * | 2010-09-10 | 2016-02-10 | 杭州民生药业有限公司 | 一种含有莫西沙星的药物组合物 |
| CN102100666B (zh) * | 2011-01-17 | 2012-07-18 | 南京新港医药有限公司 | 一种新的盐酸莫西沙星注射剂 |
| CN102093349B (zh) * | 2011-01-17 | 2012-03-07 | 南京新港医药有限公司 | 一种工业化生产盐酸莫西沙星的方法 |
| CN102688183B (zh) * | 2011-03-21 | 2016-04-06 | 重庆医药工业研究院有限责任公司 | 一种稳定的盐酸莫西沙星注射剂 |
| KR101435244B1 (ko) * | 2011-04-12 | 2014-08-29 | 씨제이헬스케어 주식회사 | 목시플록사신 수성 제형 및 이의 제조방법 |
| KR101327904B1 (ko) * | 2011-08-16 | 2013-11-13 | 대한약품공업 주식회사 | 목시플록사신 염산염의 주사제형 |
| RU2472507C1 (ru) * | 2012-02-01 | 2013-01-20 | Закрытое акционерное общество "Брынцалов-А" | Водный состав на основе моксифлоксацина для парентерального введения |
| CN102600093B (zh) * | 2012-04-11 | 2013-06-05 | 南京优科生物医药有限公司 | 一种莫西沙星片剂及其制备方法 |
| GR1008168B (el) | 2013-03-14 | 2014-04-08 | "Φαρματεν Α.Β.Ε.Ε.", | Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου |
| CN103191056B (zh) * | 2013-04-28 | 2014-10-22 | 南京海融医药科技有限公司 | 莫西沙星的口服液体制剂及其制备方法和应用 |
| WO2015093669A1 (ko) * | 2013-12-20 | 2015-06-25 | 씨제이헬스케어 주식회사 | 목시플록사신 수성 제형 및 이의 제조방법 |
| CN103976944A (zh) * | 2014-05-16 | 2014-08-13 | 成都青山利康药业有限公司 | 一种盐酸莫西沙星氯化钠注射液 |
| CN104771359A (zh) * | 2015-04-02 | 2015-07-15 | 南京正大天晴制药有限公司 | 一种稳定的盐酸莫西沙星注射液 |
| CN105640876B (zh) * | 2016-01-07 | 2019-04-12 | 天津红日药业股份有限公司 | 一种盐酸莫西沙星氯化钠注射液的制备工艺 |
| US20180318319A1 (en) | 2017-05-04 | 2018-11-08 | Ocular Science, Inc. | Compositions and Methods for Treating Eyes and Methods of Preparation |
| EP3578182A1 (en) * | 2018-06-05 | 2019-12-11 | Bayer Animal Health GmbH | Formulations containing triazinones and iron with a low amount of free iron ions |
| US11071724B2 (en) | 2019-05-17 | 2021-07-27 | Ocular Science, Inc. | Compositions and methods for treating presbyopia |
| CN111388415A (zh) * | 2020-03-19 | 2020-07-10 | 石家庄四药有限公司 | 一种盐酸莫西沙星氯化钠注射液及其制备方法 |
| WO2022092868A1 (ko) | 2020-10-29 | 2022-05-05 | 주식회사태준제약 | 안과용 조성물 |
| CN115944586B (zh) * | 2023-01-17 | 2024-12-17 | 江苏睿实生物科技有限公司 | 一种盐酸莫西沙星制剂的制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3537761A1 (de) * | 1985-10-24 | 1987-04-30 | Bayer Ag | Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure |
| JPH01258620A (ja) * | 1988-04-08 | 1989-10-16 | Dai Ichi Seiyaku Co Ltd | 耳疾患用局所製剤 |
| DE3906365A1 (de) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
| AU5449590A (en) * | 1989-04-28 | 1990-11-29 | Daiichi Pharmaceutical Co., Ltd. | Anti-hiv drug |
| CA2072366C (en) | 1989-12-29 | 2002-08-20 | Laman A. Al-Razzak | Carboxylic acid-metal ion-acid complexes |
| US5084276A (en) | 1990-01-05 | 1992-01-28 | Abbott Laboratories | Quinolone carboxylic acid compositions with polymeric additive to reduce vein irritation |
| FR2681863B1 (fr) | 1991-09-27 | 1995-02-03 | Rhone Dpc Europ | Solution de sparfloxacine sa preparation et sel la constituant. |
| DE4306417A1 (de) * | 1993-03-02 | 1994-09-08 | Grace Gmbh | Vorrichtung und Verfahren zum Verbrennen oxidierbarer Bestandteile in einem zu reinigenden Trägergas |
| CA2152828A1 (en) * | 1993-03-16 | 1994-07-07 | Shin-Ichi Uesato | 8-methoxy-quinolonecarboxylic acid derivatives |
| KR960000223A (ko) | 1994-06-08 | 1996-01-25 | 김정순 | 신규한 피리돈 카르복실산 화합물을 함유한 수용액 및 이의 제조방법 |
| DE69618987T2 (de) * | 1995-12-21 | 2002-11-21 | Pfizer Inc., New York | Injizierbare quinolonformulierungen |
| JPH1192375A (ja) * | 1997-09-25 | 1999-04-06 | Morinaga Milk Ind Co Ltd | ニューキノロン系抗菌剤の抗菌性を増強させる抗菌剤 |
| AR020661A1 (es) | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento |
| BR9915208A (pt) * | 1998-11-10 | 2001-07-31 | Bayer Ag | Preparado farmacêutico de moxifloxacina |
| DE19937115A1 (de) * | 1999-08-06 | 2001-02-08 | Bayer Ag | Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon |
| DE19937116A1 (de) | 1999-08-06 | 2001-02-08 | Bayer Ag | Moxifloxacin Kochsalzformulierung |
-
1999
- 1999-08-06 DE DE19937116A patent/DE19937116A1/de not_active Withdrawn
-
2000
- 2000-07-06 HN HN2000000115A patent/HN2000000115A/es unknown
- 2000-07-25 CN CNB008114277A patent/CN1246039C/zh not_active Ceased
- 2000-07-25 JP JP2001514981A patent/JP5522877B2/ja not_active Expired - Lifetime
- 2000-07-25 SK SK168-2002A patent/SK285650B6/sk not_active IP Right Cessation
- 2000-07-25 SI SI200030479T patent/SI1206281T1/xx unknown
- 2000-07-25 CZ CZ20020458A patent/CZ298768B6/cs not_active IP Right Cessation
- 2000-07-25 RU RU2002106399/15A patent/RU2260429C9/ru active
- 2000-07-25 PL PL353405A patent/PL198132B1/pl unknown
- 2000-07-25 CA CA002378424A patent/CA2378424C/en not_active Expired - Lifetime
- 2000-07-25 KR KR1020027001575A patent/KR100735788B1/ko not_active Expired - Lifetime
- 2000-07-25 AT AT00947994T patent/ATE270104T1/de active
- 2000-07-25 AU AU61596/00A patent/AU771058B2/en not_active Expired
- 2000-07-25 BR BRPI0013010A patent/BRPI0013010B8/pt not_active IP Right Cessation
- 2000-07-25 DE DE50006974T patent/DE50006974D1/de not_active Expired - Lifetime
- 2000-07-25 WO PCT/EP2000/007098 patent/WO2001010465A1/de not_active Ceased
- 2000-07-25 HU HU0203619A patent/HU229571B1/hu unknown
- 2000-07-25 UA UA2002031831A patent/UA72268C2/uk unknown
- 2000-07-25 EP EP00947994A patent/EP1206281B1/de not_active Expired - Lifetime
- 2000-07-25 EE EEP200200060A patent/EE04771B1/xx unknown
- 2000-07-25 PT PT00947994T patent/PT1206281E/pt unknown
- 2000-07-25 HK HK03101660.4A patent/HK1049615B/zh unknown
- 2000-07-25 HR HR20020198A patent/HRP20020198B1/xx not_active IP Right Cessation
- 2000-07-25 NZ NZ516969A patent/NZ516969A/en not_active IP Right Cessation
- 2000-07-25 IL IL14755300A patent/IL147553A0/xx active IP Right Grant
- 2000-07-25 DK DK00947994T patent/DK1206281T3/da active
- 2000-07-25 MX MXPA02001254A patent/MXPA02001254A/es active IP Right Grant
- 2000-07-25 US US10/049,095 patent/US6548079B1/en not_active Expired - Lifetime
- 2000-07-25 ES ES00947994T patent/ES2223549T3/es not_active Expired - Lifetime
- 2000-07-31 AR ARP000103958A patent/AR025001A1/es not_active Application Discontinuation
- 2000-08-01 GT GT200000123A patent/GT200000123A/es unknown
- 2000-08-01 TW TW089115369A patent/TWI238719B/zh not_active IP Right Cessation
- 2000-08-02 CO CO00058178A patent/CO5190677A1/es not_active Application Discontinuation
- 2000-08-03 UY UY26269A patent/UY26269A1/es not_active IP Right Cessation
- 2000-08-04 MY MYPI20003581 patent/MY125356A/en unknown
- 2000-08-04 PE PE2000000778A patent/PE20010400A1/es not_active IP Right Cessation
-
2002
- 2002-01-10 IL IL147553A patent/IL147553A/en unknown
- 2002-01-10 ZA ZA200200215A patent/ZA200200215B/en unknown
- 2002-01-30 CU CU20020028A patent/CU23367A3/es unknown
- 2002-01-30 BG BG106366A patent/BG65304B1/bg unknown
- 2002-02-01 NO NO20020526A patent/NO320743B1/no not_active IP Right Cessation
- 2002-02-05 MA MA26508A patent/MA25427A1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003506416A5 (enExample) | ||
| CA2378424A1 (en) | Moxifloxacin formulation containing common salt | |
| RU2002106399A (ru) | Составы моксифлоксацина, содержащие поваренную соль | |
| JP2003528798A5 (enExample) | ||
| WO2002019969A3 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
| JP2008526757A5 (enExample) | ||
| JP2002363097A5 (enExample) | ||
| AP1760A (en) | Platinum derivative pharmaceutical formulations. | |
| JP2007507538A5 (enExample) | ||
| EP1537859A3 (en) | Azithromycin dosage forms with reduced side effects | |
| KR970704472A (ko) | 수성 리스페리돈 제제(aqueous risperidone formulations) | |
| RU2001108569A (ru) | Стабилизированная фармацевтическая композиция в лиофилизированной форме | |
| AU678344B2 (en) | Lipophilic oligosaccharide antibiotic salt compositions | |
| JPH1160505A (ja) | 防腐組成物 | |
| CY1107819T1 (el) | Φαρμακευτικη διαμορφωση της ολανζαπινης | |
| DK1561460T3 (da) | Nanopartikler til indgivelse af aktive ingredienser, fremgangsmåde til fremstilling af nævnte partikler og komposition, som omfatter det samme | |
| CA2389032A1 (en) | Preventive or therapeutic agents for inflammatory diseases of intestine | |
| WO2002053149A3 (de) | Arzneimittel enthaltend ein polyamin als wirksubstanz | |
| NO20063277L (no) | Farmasoytisk sammensetning av vinflunin som er ment for parenteral administrering, fremstillingsmate og anvendelse derav | |
| JP2002537232A5 (enExample) | ||
| JP2002515439A5 (enExample) | ||
| JP2002537246A5 (enExample) | ||
| JP2003517462A5 (enExample) | ||
| CA2353205A1 (en) | Agent for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient | |
| WO2001045727A3 (en) | Stabilized veterinary compositions comprising more than one antiviral agent |